Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 6/20 | 0.48 |
| ▸ | MEN1 | O00255 | 5/20 | 0.48 |
| ▸ | MAPT | P10636 | 4/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | THRB | P10828 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 2/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | GRM1 | Q13255 | 2/20 | 0.34 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.34 |
| ▸ | GRM4 | Q14833 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6739705 | 0.76 | ATM (0.42) | KMT2AMEN1ALDH1A1LMNAHTT | |
| SCHEMBL6736592 | 0.76 | ATM (0.42) | KMT2AMEN1ALDH1A1LMNAHTT | |
| SCHEMBL17030280 | 0.73 | POLB (0.43) | KMT2AMEN1MAPTMAPK1ALDH1A1 | |
| SCHEMBL29323635 | 0.65 | EPHX1 (0.42) | KMT2AMEN1MAPTMAPK1ALDH1A1 | |
| SCHEMBL15704729 | 0.63 | GAA (0.38) | KMT2AMEN1MAPTMAPK1ALDH1A1 | |
| Nitric Acid SCHEMBL11625480 | 0.61 | ALDH1A1 (0.44) | KMT2AMEN1MAPTALDH1A1LMNA | |
| SCHEMBL23342642 | 0.60 | RIPK1 (0.38) | KMT2AMEN1POLB | |
| SCHEMBL23298057 | 0.60 | RIPK1 (0.38) | KMT2AMEN1POLB | |
| SCHEMBL23298060 | 0.60 | RIPK1 (0.38) | KMT2AMEN1POLB | |
| SCHEMBL23298019 | 0.60 | RIPK1 (0.38) | KMT2AMEN1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170368015-A1 | NOVEL COMPOUND AND ANTIVIRAL AGENT CONTAINING SAME AS ACTIVE INGREDIENT | NATIONAL UNIVERSITY CORPORATION CHIBA UNIVERSITY (JP) | 2017-12-28 | — | — | US | claimed |
| US-20170368015-A1 | NOVEL COMPOUND AND ANTIVIRAL AGENT CONTAINING SAME AS ACTIVE INGREDIENT | NATIONAL UNIVERSITY CORPORATION CHIBA UNIVERSITY (JP) | 2017-12-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170368015-A1 | NOVEL COMPOUND AND ANTIVIRAL AGENT CONTAINING SAME AS ACTIVE INGREDIENT | SARS1, ZC3HAV1, ZC3HAV1L | KMT2A 3615/4885MEN1 4555/4885MAPT 4702/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.